Jensen Huang Tells CNBC Nvidia Is Out of China. Huawei's 2026 Order Book Reportedly Hit $12 Billion.

Jensen Huang Tells CNBC Nvidia Is Out of China. Huawei's 2026 Order Book Reportedly Hit $12 Billion.

On a May 21 CNBC appearance, Jensen Huang — CEO of Nvidia, the dominant Western GPU maker — said of Huawei's domestic chip ecosystem: "Huawei is very, very strong... their local chip ecosystem performs well because we are out of that market." That's not spin. That's the architect of the world's most valuable semiconductor company publicly conceding an entire region.

The numbers behind that concession are significant. According to a Reuters readout cited in the r/investing discussion, Huawei's Ascend chip division has reportedly crossed $12 billion in orders for 2026, up roughly 60% year-over-year — though commenters flagged that figure as one to treat with caution pending further confirmation. Washington did reportedly clear approximately ten Chinese companies to import up to 75,000 H200 chips each, but according to the discussion, Beijing directed those companies to consolidate on domestic silicon instead. The result: Nvidia's China revenue is, by most accounts, effectively zero.

For investors trying to express this trade from U.S. markets, the options are thin. As one commenter noted, you can't buy Huawei directly. ETFs like KWEB miss the semiconductors story entirely; MCHI casts too wide a net; CNQQ — which holds Huawei supply chain names like ZTE, Cambricon, and SMIC — is the closest fit on paper, but its trading volume is so low that meaningful position-sizing could move the price. The right thesis, wrong vehicle problem.

Gobble's Take: Huang's quote is the kind of line that gets cited in market history books — the question is whether there's a liquid, U.S.-listed way to trade what comes next.

Source: r/investing

The Stocks That Already Ran 400% Are Still the Most-Discussed. So What's Actually Left?

A recurring tension in r/stocks right now: the names getting the most attention have already made their moves. ASTS and RKLB are both up roughly 300–400%, according to one r/stocks discussion. NBIS is up over 440% in a year. NOK, after a long period of stagnation, has gained about 150% in the past six months. By the time a stock is trending on Reddit, the easy money is often gone.

The same discussion flagged a second tier of names — INFQ, NOW, MU, and NOVO — that haven't had equivalent runs but carry more uncertainty. NOW drew attention partly because a number of U.S. congressmembers reportedly bought into it, according to the post. NOVO was mentioned as a potential play relative to Eli Lilly, though the original poster noted clear reluctance there. One commenter pushed back on the "already ran too far" instinct, arguing that high can go higher in a forward-looking market and that the right move is to assess remaining upside rather than anchor to past performance. Another went the other direction: "I'm starting to think we might be in the bubble phase — 'it can't possibly go down.'"

The poster's own setup — $1,000 per month, mostly in ETFs, with occasional single-stock positions — is a reasonable framework, but the question of whether to deploy now or wait for a tariff- or geopolitics-driven dip has no clean answer in the source material, and anyone claiming otherwise is speculating.

This briefing reflects discussion from public investing forums and does not constitute financial advice. Please consult a qualified financial professional before making investment decisions.

Gobble's Take: In a market where the stocks everyone agrees on have already tripled, "do your research" is less a cliché and more the only honest answer.

Source: r/stocks

In Case You Missed It

Yesterday's top stories:

• SpaceX Is Skipping the Standard 180-Day Insider Lock-Up — Here's What That Means for New Shareholders
• Abbott Labs Is Down 32% Over the Past Year. Analysts Still Rate It a Strong Buy.
• QXO Is Trading at Less Than Half Its Median Analyst Target — With Losses to Match